Interaction between the tetracyclic antidepressant
mianserin HCl and opioid receptors
by
Schreiber S, Backer MM, Kaufman JP, Pick CG
Department of Psychiatry C,
the Chaim Sheba Medical Center,
Tel-Hashomer and the Tel-Aviv University
Sackler School of Medicine, Israel.
Eur Neuropsychopharmacol 1998 Dec;8(4):297-302

ABSTRACT

The antinociceptive effects of the tetracyclic antidepressant mianserin and its interaction with various opioid receptor subtypes was evaluated. Mice were tested with a hotplate analgesia meter. Mianserin elicited an antinociceptive effect in a dose-dependent manner following doses from 1-25 mg/kg. As the mianserin dose increased beyond 30 mg/kg, latencies returned to baseline, yielding a biphasic effect. This effect of mianserin was antagonized by naloxone (P<0.005), implying a possible opioid mechanism of action involved in the mianserin induced antinociceptive effect. When administered with various opioid antagonists, the sensitivity of mianserin to selective opioid antagonists was found significant for mu and kappa1 opioid receptor subtypes (P<0.005), but not for delta-receptor. At the next stage mianserin was administered together with various agonists of opioid receptors. When administered together with opiates, mianserin significantly potentiates analgesia at the mu, kappa1 and kappa3 opioid receptor subtype (P<0.005) and to a lesser extent, at the delta opioid receptors. These results suggest a potential use of mianserin in the management of some pain syndromes. However, further research is needed in order to establish both the exact clinical indications and the effective doses of mianserin when prescribed for pain.

5-HT2c
Opioids
Mianserin
Ritanserin
Buprenorphine
Mianserin (Bolvidon) and depression
Refs
HOME
HedWeb
Cocaine.org
Mianserin.com
Future Opioids
BLTC Research
Superhappiness?
Paradise-Engineering
The Abolitionist Project
The Hedonistic Imperative
MDMA: Utopian Pharmacology

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family